Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis

ConclusionsSerum HGF was increased in male AS patients and associated with higher mSASSS and lower BMD. In addition, serum HGF was positively associated with risk factors for osteoproliferation such as age, CRP and smoking. HGF could be a potential biomarker of importance for the bone metabolism in AS.Trial registrationNCT00858819.

http://link.springer.com/10.1007/s00198-018-4721-4

Source: Osteoporosis International - October 10, 2018 Category: Orthopaedics Source Type: research